Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice

Abstract

Autoantigen-specific immunological tolerance represents a central objective for prevention of type 1 diabetes (T1D). Previous studies demonstrated mucosal antigen administration results in expansion of Foxp3+ and LAP+ regulatory T cells (Tregs), suggesting oral delivery of self-antigens might represent an effective means for modulating autoimmune disease. Early preclinical experiments using the non-obese diabetic (NOD) mouse model reported mucosal administration of T1D-related autoantigens [proinsulin or glutamic acid decarboxylase 65 (GAD)] delayed T1D onset, but published data are conflicting regarding dose, treatment duration, requirement for combinatorial agents, and extent of efficacy. Recently, dogma was challenged in a report demonstrating oral insulin does not prevent T1D in NOD mice, possibly due to antigen digestion prior to mucosal immune exposure. We used transplastomic plants expressing proinsulin and GAD to protect the autoantigens from degradation in an oral vaccine and tested the optimal combination, dose, and treatment duration for the prevention of T1D in NOD mice. Our data suggest oral autoantigen therapy alone does not effectively influence disease incidence or result in antigen-specific tolerance assessed by IL-10 measurement and Treg frequency. A more aggressive approach involving tolerogenic cytokine administration and/or lymphocyte depletion prior to oral antigen-specific immunotherapy will likely be required to impart durable therapeutic efficacy.

The membrane tethered transcription factor EcbZIP17 from finger millet promotes plant growth and enhances tolerance to abiotic stresses

“…One-way analysis of variance (ANOVA) was performed to determine significant differences between the means within each treatment at p < 0.05. GraphPad Prism 5.0 software (Graph Pad, USA) was used for statistical analysis 74 . Lower case letters were used to indicate the significant difference above the error bars.…”

Noninvasive vaccination against infectious diseases

“…Therefore, there are more stringent requirements for the vaccine carrier to achieve an efficient immune response, as a larger dose may lead to risks of immune tolerance, and constant antigen stimulation of the GI tract may limit the response of the GALT to biohazard antigens rather than protecting against these antigens. 201 , 202 …”

Lettuce‐produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination

“…Oral delivery of recombinant plant‐produced vaccines is a desirable means of vaccination due to the simplicity and safety of administration. The cost of downstream processing is usually about 80% of the production cost for plant‐made pharmaceuticals and vaccines (Chan and Daniell, ; Posgai et al ., ; Shahid and Daniell, ). Thus, edible crops offer unique cost advantages.…”